This seminar will help you understand in detail the application of FDA’s latest guidance on the use of social media in presenting and promoting information about drug products and medical devices subject to FDA regulation. This is critical in order to develop the appropriate strategy, policies and procedures to ensure compliance.
As social media use explodes, companies in FDA-regulated industries will need to understand the current and pending regulations in order to meet compliance requirements. The attendees will be provided with the FDA’s current thinking and the rationale behind it. The attendees will also learn ways to meet compliance objectives in a cost-beneficial manner.
- Pros and cons of using social media venues
- Compliant use of Social Media in an FDA-regulated Environment
- FDA draft guidance documents
- Balancing benefit and risk information on social media
- Managing character space limitations on social media
- Managing misinformation posted by independent third-parties
- Pending regulatory action by the US Congress
- Information Technology Departments
- Medical Affairs Departments
- Clinical Data Departments
- Marketing Departments
- Compliance Departments
- Regulatory Affairs Departments
- GMP Training Specialists
- Business Stakeholders responsible for product presentation and promotional content
- Consultants working in the life sciences industry who are involved in product presentation and promotional content
- This webinar will also benefit any consultants working in the tobacco or life science industries who are involved in computer system implementation, validation and compliance
FDB2141